TTP Labtech Announces Company Growth
News May 11, 2012
Natural innovator, TTP Labtech, has strengthened its in-house team and commitment to product development following a successful 2011, which saw revenue increase by 5%.
Having invested heavily in R&D in 2011, with 100% of resources focused solely on product development, TTP Labtech has launched an impressive number of products this year alone, with more launches planned for later in 2012.
Utilizing a commercial-focused but still consultative approach, which involves listening carefully to customers and developing products that closely meet their needs, TTP Labtech has further built on its strong reputation as an innovative yet approachable industry partner.
With a sales increase of 16% in products, 14% in consumables and 7% in sales across Asia, TTP Labtech expects this growth trend to continue throughout 2012.
Established leaders within the liquid handling, cell based screening and sample management fields, TTP Labtech has continued to develop innovative solutions within these arenas, while also extending its product offering to include new application areas, including PCR (mosquito® HV), biobanking (arktic) and analytical chemistry (aequus).
Following the recent launch of its new microlitre flow calorimeter for high-throughput enzyme screening, chipCAL, TTP Labtech has also entered the food industry market for the first time, illustrating the company’s commitment to further expansion during 2012.
To support company growth, TTP Labtech has expanded its in-house team of scientists, engineers and automation experts, with a series of promotions and new appointments to drive the company forward.
The most significant of which is the promotion of Jas Sanghera, former Commercial Manager, to Managing Director.
He commented “I am delighted to be taking on the role of Managing Director, as it will enable me to strengthen our marketing and sales activities, while maintaining responsibility for the products. One of the factors which set TTP Labtech apart is our reputation for robustness, reliability, and customer service. With new innovations launching alongside our existing offering it is an exciting time for TTP Labtech.”
The newly appointed members will complement the current team, to maintain TTP Labtech’s stance as Natural Innovators in the creation, development, design and manufacture of instrumentation, providing novel, high calibre solutions for the biotechnology and pharmaceutical industries, and academia.
Providing the company with a solid marketing position, Barbara Bengyel has been appointed as Marketing Manager, while Andrew Goulter has been employed as Distributor Network Manager to expand and support product distribution.
Finally, following the division of the products into two main product lines, automation and instrumentation, Joby Jenkins has been promoted to Global Sales Manager for Automation, and David Sharp has been recently appointed as Global Sales Manager for Instrumentation.
The Friedrich Schiller University Jena Partners with ACD/Labs to Advance its Analytical Data Management StrategyNews
Implementation of ACD/Spectrus as an analytical data management system helps researchers and students streamline NMR and MS data processing, interpretation, collaboration, and training.READ MORE
New Ovarian Cancer TargetNews
Researchers have found a prescription drug, Calcitriol, approved by the Food and Drug Administration for the treatment of calcium deficiency and kidney diseases, may increase the likelihood of surviving ovarian cancer. This new study opens a potential avenue for treating ovarian cancer. Since Calcitriol is an FDA-approved drug, no additional research is needed before the drug can advance to human clinical trials for ovarian cancer.READ MORE
Novel Microplate 3D Bioprinting Platform for Engineering Muscle and Tendon TissuesNews
There is a strong need for medication that treats age-related degenerative muscle and tendon diseases. A critical bottleneck in the discovery and development of novel drugs for skeletal muscle is the lack of efficient and robust functional in vitro assays for compound screening. Researchers describe the development of a novel screening platform with automated production of 3D muscle- and tendon–like tissues using 3D bioprinting.READ MORE